Good MorningEquity markets eked out small gains on Wednesday after the CPI report came in as expected. The report shows that consumer-level inflation is cooling in alignment with the outlook for FOMC rate cuts, but not so quickly that it raises the risk of recession. The takeaway is that the US economy is on track for a shift that should reinvigorate activity, but risks remain. Among them is the possibility that lower rates will reinvigorate inflation and keep the FOMC from cutting quickly.
The next major hurdle for the market is today. The combination of retail sales data and Walmart results will give a clear indication of spending habits and help the market assess the recession risks. So long as consumer spending is solid, the US economy is unlikely to experience an economic contraction, although slowing is not out of the question. An environment of lower but still high interest rates and persistent inflation could easily lead to a period of stagflation. Featured: Trump Just Gave the Green Light to Rewrite Social Security? (Ad) 
|
Markets | | | Wall Street rallied to one of its best days of the year Thursday after data showed the U.S. economy is holding up better than expected, with particular credit going to the country’s shoppers. The S&P 500 jumped 1.6% for its fourth-best day of the year and its sixth straight gain as the U.S. stoc... Read the Full Story |
|
From Our PartnersAs you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | | | We also revealed how you can find and execute these setups on your own without any help at all. |
|
Markets | | |
Wall Street analysts understand that their reputations and careers are on the line each time they issue a recommendation for—or against—a stock. Knowing this, investors would find the weight of the decision-making and stock rating all the more important now that the S&P 500 has sur... Read the Full Story |
|
Markets | | |
Whether the product of genuine market forces or psychology, the September Effect — the tendency for September to be, on average, the worst month of the year for the market — can have a very real impact. Couple that with mounting fears of a recession, and things get even more uncertain ... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | |
Brinker International’s (NYSE: EAT) stock price fell 15% following its Q4 release, which presented an appetizing dip for investors to snack on. Weaker-than-expected earnings and softer-than-expected guidance caused the dip, but that is the worst news to be found. The remaining details prov... Read the Full Story |
|
Markets | | |
Serve Robotics (NASDAQ: SERV) is up by double-digits following its Q2 release and may continue increasing because of its operational improvements. However, every positive detail is offset by a negative, raising doubts about the stock price trajectory. The market for SERV remains below a critical... Read the Full Story |
|
|
Markets | | | Japan’s economy grew at an annual rate of 3.1% in the April-June period, rebounding from the contraction in the previous quarter, government data showed Thursday. The world’s fourth largest economy grew 0.8% in the fiscal first quarter, according to the Cabinet Office.Seasonally adjusted gross domes... Read the Full Story |
|
Markets | | | Warren Buffett offered more details Wednesday about the stocks he has been selling lately, including confirming that he sold more than 389 million Apple shares during the second quarter.Berkshire Hathaway still owns 400 million shares of the iPhone maker, so it remains the biggest position in the co... Read the Full Story |
|
Stocks | | | More sunshine could be in the forecast for solar power companies like SolarEdge Technologies and Sunrun, whose stock prices have been dimmed by high interest rates.Wall Street is betting that those high rates could start coming down by September. The Fed's key rate is at a two-decade high, making bo... Read the Full Story |
|
Markets | | | Dubai-based port operator DP World has reported its half-year profits fell by nearly 60%, in part over the ongoing attacks by Yemen’s Houthi rebels over the Israel-Hamas war that have affected shipping through the Red Sea Read the Full Story |
|
Markets | | |
Canopy Growth (NASDAQ: CGC) is one of the North American players in the cannabis industry. The company’s shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated. The company's value reached nearly $20 billion in early 2021 but now sits at just $57... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. | | View Today's Stock Pick |
|
